Rossmore Private Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.5M Sell
100,354
-417
-0.4% -$97.1K 2.15% 10
2025
Q4
$20.9M Buy
100,771
+14,527
+17% +$2.87M 1.86% 14
2025
Q3
$16M Sell
86,244
-543
-0.6% -$93K 1.72% 12
2025
Q2
$13.3M Buy
86,787
+137
+0.2% +$21.1K 1.55% 14
2025
Q1
$14.4M Sell
86,650
-462
-0.5% -$72.3K 1.77% 11
2024
Q4
$12.6M Sell
87,112
-1,108
-1% -$172K 1.56% 14
2024
Q3
$14.3M Buy
88,220
+395
+0.4% +$62.9K 1.77% 10
2024
Q2
$12.8M Sell
87,825
-1,966
-2% -$292K 1.69% 11
2024
Q1
$14.2M Buy
89,791
+97
+0.1% +$15.4K 1.86% 10
2023
Q4
$14.1M Buy
89,694
+17
+0% +$2.61K 1.99% 9
2023
Q3
$14M Sell
89,677
-7,538
-8% -$1.24M 2.12% 7
2023
Q2
$16.1M Sell
97,215
-1,236
-1% -$199K 2.39% 6
2023
Q1
$15.2M Sell
98,451
-56
-0.1% -$9.04K 2.37% 6
2022
Q4
$17.4M Buy
98,507
+1,423
+1% +$246K 2.79% 6
2022
Q3
$15.9M Buy
97,084
+1,370
+1% +$232K 2.84% 6
2022
Q2
$17M Buy
95,714
+1,485
+2% +$265K 2.94% 6
2022
Q1
$16.7M Buy
94,229
+507
+0.5% +$86.3K 2.6% 6
2021
Q4
$16M Buy
93,722
+435
+0.5% +$71.2K 2.5% 6
2021
Q3
$15.1M Buy
93,287
+134
+0.1% +$22.9K 2.58% 7
2021
Q2
$15.5M Buy
93,153
+1,243
+1% +$206K 2.65% 7
2021
Q1
$15.1M Buy
91,910
+1,094
+1% +$177K 2.83% 6
2020
Q4
$14.3M Buy
90,816
+1,252
+1% +$185K 2.9% 7
2020
Q3
$13.3M Buy
89,564
+14,183
+19% +$2.1M 3.13% 7
2020
Q2
$10.6M Buy
75,381
+4,693
+7% +$684K 2.93% 7
2020
Q1
$9.28M Buy
70,688
+12,170
+21% +$1.73M 3.21% 6
2019
Q4
$8.54M Buy
58,518
+274
+0.5% +$37.2K 2.63% 7
2019
Q3
$7.54M Buy
58,244
+132
+0.2% +$17.4K 2.53% 8
2019
Q2
$8.09M Buy
58,112
+645
+1% +$89.3K 2.86% 5
2019
Q1
$8.03M Buy
57,467
+392
+0.7% +$52.5K 2.96% 6
2018
Q4
$7.37M Buy
57,075
+18,792
+49% +$2.62M 3.12% 5
2018
Q3
$5.29M Buy
38,283
+338
+0.9% +$44.9K 2.12% 9
2018
Q2
$4.6M Buy
37,945
+30,627
+419% +$3.82M 2.97% 8
2018
Q1
$938K Sell
7,318
-1,586
-18% -$214K 0.95% 27
2017
Q4
$1.24M Buy
+8,904
New +$1.24M 1.25% 19

Other funds holding JNJ

Rossmore Private Capital's JNJ Position: Q1 2026 in Review

Rossmore Private Capital reduced its Johnson & Johnson (JNJ) stake by 0.41% in Q1 2026, selling an estimated $97.1K and leaving 100,354 shares worth $24.5M. The position accounts for 2.15% of the portfolio, ranked #10.

Rossmore Private Capital first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Rossmore Private Capital held 100,354 shares of Johnson & Johnson worth $24.5M as of Q1 2026.
  • Rossmore Private Capital sold 417 Johnson & Johnson shares in Q1 2026, an estimated $97.1K.
  • Johnson & Johnson made up 2.15% of Rossmore Private Capital's portfolio in Q1 2026, its #10 holding.
  • Rossmore Private Capital first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Rossmore Private Capital's 13F filing for Q1 2026, filed 1 May 2026.